Editorial: Portacaval anastomosis for metabolic disease.
D000367:Age Factors; D000641:Ammonia / Q000097:blood; D002648:Child; D002675:Child, Preschool; D002784:Cholesterol / Q000097:blood; D005500:Follow-Up Studies; D006008:Glycogen Storage Disease / Q000628:therapy*; D006579:Heterozygote; D006720:Homozygote; D006801:Humans; D006937:Hypercholesterolemia / Q000235:genetics / Q000628:therapy*; D006949:Hyperlipidemias / Q000235:genetics* / Q000628:therapy*; D007223:Infant; D008077:Lipoproteins, LDL / Q000096:biosynthesis / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D008112:Liver Glycogen / Q000378:metabolism; D009203:Myocardial Infarction / Q000175:diagnosis; D011167:Portacaval Shunt, Surgical; D011183:Postoperative Complications
D008077:Lipoproteins, LDL; D008112:Liver Glycogen; D000641:Ammonia; D002784:Cholesterol